Chlorpromazine, the prototype phenothiazine tranquilizer, inhibited the growth and killed organisms of the genus Bordetella. There were striking differences, however, among the three Bordetella species. Bordetella pertussis was most susceptible, with some inhibition of growth at .4 ,ug/ml and killing at 16 ,g of chlorpromazine per ml. Bordetella parapertussis and Bordetella bronchiseptica were less susceptible, with killing at 32 and 256 ,ug/ml, respectively. Although the phenothiazines were inhibitory for Bordetella extracytoplasmic adenylate cyclase, the lethal effect occurred at a lower concentration and did not appear to involve modification of the enzyme activity. Exposure of B. pertussis to combinations of chlorpromazine and erythromycin resulted in impaired growth at concentrations lower than that of either drug alone, but there was no evidence that the two drugs interacted either synergistically or antagonistically.
Bordetella species are unique in their production of adenylate cyclase, which is predominantly extracytoplasmic in location and is dependent upon the eucaryotic, calcium-dependent regulatory protein calmodulin for activation (2) (3) (4) (5) . As with other calmodulin-mediated effects, activation of the enzyme is inhibited by phenothiazine tranquilizers, such as chlorpromazine and trifluoperazine (2, 3, 23) . While investigating the pharmacological effect of these agents on cultures of Bordetella pertussis, we discovered that the organisms were inhibited and killed. In the present study, the characteristics of the inhibitory and lethal effects of chlorpromazine for Bordetella species are presented and contrasted with previously observed effects of phenothiazines on other bacteria (9) (10) (11) (12) (13) (14) 21) .
MATERIALS AND METHODS
Bacterial strins and culture conditions. Four strains of B. pertussis and two each of Bordetella parapertussis and Bordetella bronchiseptica were studied. The characteristics of each strain are given in Table 1 . Organisms were stored frozen at -70°C in skim milk and reconstituted for study. Primary culture for 48 h was carried out on Bordet-Gengou agar containing 20%6 sheep blood. Thereafter, each strain was inoculated into modified synthetic Stainer-Scholte medium (5) and cultured for an additional 24 h. At that point, the mid-exponential-phase cultures were used to inoculate nephelometer flasks for growth studies. Starting inocula ranged from 1.0 x 106 to 5.2 x 106 organisms per ml in all studies cited. Fifty-milliliter flasks containing 20 ml of medium were incubated in a New Brunswick environmental chamber oscillating at 150 rpm with room air at 35.5°C.
Drug effects on bacterial growth and viabiity. Chlorpromazine and trifluoperazine, kindly provided by Smith Kline & French Laboratories, Philadelphia, Pa., were dissolved in deionized, glass-distilled water. Serial twofold dilutions were added to duplicate culture flasks described above either immediately after inoculation with organisms or later a% indicated. Bacterial growth was monitored by turbidimetric readings on a Bausch & Lomb Spectronic 20 spectrophotometer at 650 nm.
To quantitate the phenothiazine effects in a manner that could be compared to those of other antibiotics (18) Interaction between chlorpromazine and erythromycin was evaluated by carrying out the MIC and MBC assays as described above, except twofold dilutions of both drugs were added at the time of culture inoculation.
Adenylate cyclase ay. The extracytoplasmic adenylate cyclase of B. pertussis was assayed as described previously (5) . Enzyme activity was deter- 
RESULTS
When B. pertussis was cultured in synthetic Stainer-Scholte medium, the addition of chlorpromazine produced a dose-dependent inhibition of growth ( Fig. 1) . Whereas 2 pg of chlorpromazine per ml was without apparent effect, 4 ,ug/ml resulted in reduced growth and 8 gg/ml totally prevented growth of the culture. Trifluoperazine (MIC, 8 pg/ml), but not the chlorpromazine metabolite, chlorpromazine-5-oxide (no effect up to 64 ,ug/ml), caused growth inhibition and killed B. pertussis (data not shown).
Because chlorpromazine inhibited the extracytoplasmic adenylate cyclase of B. pertussis (23) , it was important to determine whether the observed inhibitory effects might be mediated through alteration of the adenylate cyclase activity. A concentration of chlorpromazine which produced maximal inhibition of growth (16 pg/ ml) reduced the adenylate cyclase activity by only 8 to 10%o (data not shown). Furthermore, sodium fluoride, a potent inhibitor of B. pertussis adenylate cyclase at 10 mM (5), had no effect on the growth of the organism. Finally, B. pertussis UT25-80, which is avirulent, nontoxigenic, and produces no detectable extracytoplasmic adenylate cyclase, exhibited chlorpromazine susceptibility equivalent to that of the prototype strains. These data suggest strongly that chlorpromazine inhibition of B. pertussis growth occurs independently of its effects on adenylate cyclase.
The inhibitory effect of chlorpromazine was further evaluated by adding the drug during exponential growth rather than at the time of culture initiation (latent phase). As shown in Fig. 2 , exponentially growing B. pertussis cells were less susceptible to the inhibitory effect of chlorpromazine. A lag of approximately 10 h was seen before 16 ,ug of chlorpromazine per ml caused inhibition of growth, and 6.4 pg/ml was without effect. The decrease in absorbance with the higher doses of drug suggested that bacterial lysis was occurring, and this possibility was evaluated by quantitating viable cell counts at the termination of culture.
The effect of chlorpromazine on viability of B. pertussis paralleled its effect on growth (Fig. 3) . Final culture density of viable organisms was reduced by 4 pg/ml, and there was a net decrease in viable counts as compared to the starting inoculum at 8 and 16 pg/ml. When B. parapertussis and B. bronchiseptica were evaluated in this assay, they were found to be markedly less susceptible to the inhibitory and lethal effects of chlorpromazine (Fig. 3) . Killing of these two organisms required drug ANTIMICROB. AGENTS CHEMOTHER. T I ME (Hours) FIG. 1. Dose-dependent inhibition of B. pertussis growth by chlorpromazine. B. pertussis was cultured in synthetic Stainer-Scholte medium from an initial inoculum of 106 CFU/ml. Chlorpromazine dissolved in medium was added immediately after culture inoculation. Growth was followed by nephelometry at 650 nm. Symbols: 0, control organisms without drug. Chlorpromazine was used at 2 ,ug/ml (A), 4 ,ug/ml (A), and 8 ,ug/ml (0).
concentrations that were 8-and 32-fold higher, respectively, than those required for B. pertussis.
To make these data comparable to previously studied antibiotic susceptibilities of the Bordetella species (1), rigorous MIC and MBC determinations were carried out ( combination of chlorpromazine and erythromycin on B. pertussis was studied. As demonstrated above, the MIC for chlorpromazine alone was 8 pLg/ml. The MIC for erythromycin was 0.05 F,g/ml ( Table 3 ). The MICs of the two drugs combined, however, were 0.025 ,ug/ml for erythromycin and 4 Fg/ml for chlorpromazine. In addition, there was impaired growth at subMICs (chlorpromazine, 1 ,ug/ml, plus erythromycin, 0.025 ;Lg/ml). These data suggest that, while not strictly synergistic, the combination of these two drugs at sub-MICs is not deleterious and may result in an enhanced effect on B. pertussis. DISCUSSION Phenothiazines, most widely employed for their neuroleptic effects, have been recognized to possess antimicrobial activity (9) (10) (11) (12) (13) (14) . Chlorpromazine, the prototype of this class of drugs, is inhibitory and lethal for an array of microorganisms (11, 12) . The general pattern which has emerged from prior studies shows gram-positive organisms to be much more susceptible to these agents than gram-negative organisms. For example, the MICs of chlorpromazine for Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus range from 20 to 40 p,g/ ml, whereas those for the gram-negative organisms Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa are substantially higher at 130 to 1,250 pg/ml (12) . In light of these data, the susceptibilities of the gram-negative organisms Bordetella pertussis (MIC, 8 ,ug/ml) and Bordetella parapertussis (MIC, 32 gig/ml) are particularly striking. In contrast, the relative insusceptibility of B. bronchiseptica (MIC, 256 pg/ml) is as would be expected. The interspecies differences are of importance, since Kloos et al. have shown that the three Bordetella species are sufficiently similar by DNA hybridization to be combined into one species (8) . The biochemical basis for their differential chlorpromazine susceptibility remains to be determined but, when understood, may be useful in helping to elucidate the mechanism of the drug effect.
The reduced susceptibility of exponentially grown B. pertussis organisms to the inhibitory effect of chlorpromazine (Fig. 2) is in contrast to 
